Source: Annual Congress 2009 - Acute lung injury and biomarkers
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
S. Huang, X. Guan, K. Tang (Guangzhou, China). Ulinastatin plus thymosin-α₁ as immunotherapy improves survival in patients with sepsis. Eur Respir J 2009; 34: Suppl. 53, 781

Member's Comments

No comment yet.

Related content which might interest you: Metformin improves survival in lung cancer patients receiving EGFR-TKIs therapy> Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Dexamethasone improves antiemetic control in lung cancer patients treated with chemotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 434s Year: 2007 Short-term efficacy of advanced NSCLC patients receiving anlotinib hydrochloride as the first and second-line treatment Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Impact of antibiotics on immunotherapy response in lung cancer patients Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Efficacy and safety of erythropoietic agents in anaemic patients with lung cancer (LC) Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Pyrogenal plus aprotinin therapy of COPD patients with immune reactivity depression Source: Eur Respir J 2002; 20: Suppl. 38, 261s Year: 2002 Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011 Bevacizumab shows survival benefit for non-small lung cancer patients who received subsequent pemetrexed treatment but not had a therapeutic effect in clinical practice Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Efficacy of α-tocoferol in the treatment of patients with pneumonia Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Effect of antibiotic prophylaxis on pneumonia in cardiac arrest patients treated with therapeutic hypothermia Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Does atorvastatin have effect on lung function and morbidity as add-on therapy in asthmatic patients? Source: Annual Congress 2007 - New drugs for asthma Year: 2007 Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Early treatment response may predict long-term mepolizumab benefit in severe asthma Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020 Year: 2021 Survival and respiratory effects in NSCLC patients after treatment with inhaled carboplatin Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Comparison of extracorporeal photopheresis efficacy in treated versus non-treated patients with refractory BOS. Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006